FDA Adverse Event Malfunction Summary report: N

COBAS 6000 C501 MODULE

MDR report key: 20694117 · Received November 15, 2024

Report

Report Number
1823260-2024-03330
Event Type
Malfunction
Date Received
November 15, 2024
Date of Event
September 23, 2024
Report Date
November 15, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
UDI-DI
04015630924707
PMA / PMN Number
K060373
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
EC
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE GLUCOSE REAGENT LOT NUMBER IS 803139. THE TRIGL REAGENT LOT NUMBER AND THE REAGENT EXPIRATION DATES WERE NOT PROVIDED. THE GLUC3 CALIBRATION AND BOTH REAGENTS' QC RECOVERY DATA WERE ACCEPTABLE. THE ALARM TRACE DID NOT CONTAIN A CONSPICUOUS EVENT. THE FIELD SERVICE ENGINEER (FSE) CHANGED THE WATER FILTERS, INCREASED THE PRESSURE IN THE DETERGENT AND WATER DISPENSING PROBES, CHECKED THE GEAR PUMP, CUVETTES, AND RINSE BATH, AND CLEANED AND PURGED ALL PIPETTES. THE SERVICE MAINTENANCE ACTIONS PERFORMED BY THE FSE RESOLVED THE ISSUE.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF QUESTIONABLE GLUC3 GLUCOSE HK GEN.3 AND TRIGL TRIGLYCERIDES RESULTS FOR 2 PATIENT SAMPLES ON A COBAS 6000 C501 MODULE. FOR SAMPLE 1, THE INITIAL GLU3 RESULT WAS 6.5 MG/DL. THE REPEAT RESULT WAS 146.1 MG/DL. FOR SAMPLE 2, THE INITIAL TRIGL RESULT WAS 606.8 MG/DL. THE REPEAT RESULT WAS 93.7 MG/DL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1195388 COBAS 6000 C501 MODULE CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS 04015630924707

Patients

Seq Age Sex Outcome Treatment
1 68 YR Female ENALAPRIL (PATIENT 2)| LEVOTIROXINA (PATIENT 2)